111 related articles for article (PubMed ID: 33128955)
1. Generation of induced pluripotent stem cell line (NCKDi001-A) from a 19-year-old patient with a novel COL4A5 gene mutation in Alport syndrome.
Wang G; Wu H; Gao E; Zhang L; Chen L; Zhu Y; Zhang J; Liu Z
Stem Cell Res; 2020 Dec; 49():102023. PubMed ID: 33128955
[TBL] [Abstract][Full Text] [Related]
2. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
3. Generation of an induced pluripotent stem cell line (ZJUi007-A) from a 11-year-old patient of Fabry disease.
Zhu Y; Zhang L; Wang G; Zhao J; Hou X; Wu H; Xu Y; Mao J; Liu Z; Zhang J
Stem Cell Res; 2021 Aug; 55():102475. PubMed ID: 34365103
[TBL] [Abstract][Full Text] [Related]
4. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carrying a homozygous mutation in COL4A3 gene.
Wu H; Wang G; Gao E; Zhang L; Zhu Y; Zhang J; Liu Z
Stem Cell Res; 2021 Oct; 56():102557. PubMed ID: 34626894
[TBL] [Abstract][Full Text] [Related]
5. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene.
Gao X; Li G; Deng H; Feng W; Li Y; Liu M; Li Y
Stem Cell Res; 2021 May; 53():102388. PubMed ID: 34088015
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
Sun L; Zhang J; Kuang XY; Kang YL; Wu Y; Huang WY
Stem Cell Res; 2020 May; 45():101833. PubMed ID: 32416580
[TBL] [Abstract][Full Text] [Related]
7. Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient.
Guo X; Ji W; Niu C; Ding Y; Chen Z; Chen C; Tong H; Han Z; Chu M
Stem Cell Res; 2020 Dec; 49():102085. PubMed ID: 33202306
[TBL] [Abstract][Full Text] [Related]
8. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
Ma Y; Wang Z; Gao M; Liu X; Sun W; Gong Y; Sun G; Liu G
Stem Cell Res; 2021 May; 53():102343. PubMed ID: 33878711
[TBL] [Abstract][Full Text] [Related]
9. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
Malone AF; Funk SD; Alhamad T; Miner JH
Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of an integration-free iPSC line SDUBMSi006-A from a patient with Alport syndrome caused by COL4A3 gene mutations.
Ma Y; Wang Z; Liu X; Sun W; Gong Y; Liu G; Sun G
Stem Cell Res; 2021 Apr; 52():102237. PubMed ID: 33601099
[TBL] [Abstract][Full Text] [Related]
11. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
12. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
[TBL] [Abstract][Full Text] [Related]
13. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
14. Atypical Alport syndrome associated with a novel COL4A5 mutation.
Höpker K; Liebau MC; Friederichsohn C; Waldherr R; Benzing T
Clin Nephrol; 2009 Mar; 71(3):321-5. PubMed ID: 19281745
[TBL] [Abstract][Full Text] [Related]
15. [Identification of a novel variant of COL4A5 gene in a pedigree affected with Alport syndrome].
Liu X; Gao M; Zou Y; Wang L; Kang R; Xu P; Niu Y; Huang S; Li J; Xie H; Gao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Aug; 37(8):807-810. PubMed ID: 32761583
[TBL] [Abstract][Full Text] [Related]
16. A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome.
Baikara BT; Zholdybayeva EV; Rakhimova SE; Nigmatullina NB; Momynaliev KT; Ramanculov YM
PLoS One; 2015; 10(7):e0132010. PubMed ID: 26168235
[TBL] [Abstract][Full Text] [Related]
17. Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.
Tian L; Wu F; Bai R; Ma S; Zheng H; Liu WJ; Wang Y
Stem Cell Res; 2021 Aug; 55():102481. PubMed ID: 34419749
[TBL] [Abstract][Full Text] [Related]
18. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
[TBL] [Abstract][Full Text] [Related]
20. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
